TRP
TISSUE REP FPO [TRP]
Healthcare · ASX Small Cap
$0.1600 -11.1%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical50
Catalyst51
Sentiment50
Fundamental61
Momentum52
Risk Gate43
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Bollinger squeeze (breakout building)
- Volatility contracting (breakout setup)
- Strong cash runway (13 quarters)
- 4C filed 2026-01-30
- Low P/S ratio (4.1x)
- Moderate revenue growth (+14%)
- EPS estimates revised downward (-6pts)
- Near 52-week low (8% of range)
- Micro-cap ($5-20M) - high risk
- Altman Z-Score in grey zone (2.28)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Negative 5-day momentum (-3.0%)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-161%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Notification regarding unquoted securities - TRP
NONE Appendix 4D and Half Year Report to 31 December 2025
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-27 | Notification regarding unquoted securities - TRP |
| 2026-02-27 | Appendix 4D and Half Year Report to 31 December 2025 PRICE SENSITIVE |
| 2026-01-30 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$10.9M
Market Cap
92K
Avg Volume
0.8x
Vol Ratio
$0.15 — $0.48
52-Week Range
N/A
Short Interest
13 qtrs
Cash Runway
-26.5%
ROE
-161.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 56% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #50 of 119 · Sector avg: 51
View all Healthcare signals →